Abstract 24. Melanoma

Abstract 24. Melanoma: How Much Does Time To Treatment Matter?

RESULTS: Patients with longer times to treat tended to be male, use Medicare, have melanoma on the head and neck and have a higher melanoma stage. Younger age at diagnosis, lack of comorbidities, and lower melanoma stage favorably affected survival. After multivariate adjustment, there was no difference between patients treated in 1–30 days, 31–60 (HR 1.02, 95%CI 0.99–1.04) and 61–90(1.03, 95%C...

Abstract: Osseointegrated Orbital Reconstruction: A 24-Year Experience

Result: All patients had symmetric, natural osteotomy lines, and satisfactory facial ratios in a single-stage operation. The average relative error of VSP and post-op result on the entire skull was 0.41 ± 0.13 mm. The average new left gonial error(Go’-L Error) was 0.43 ± 0.77mm. The average new right gonial error(Go’-R Error) was 0.45 ± 0.69mm. The Average pognion error(Pg error) was 0.79 ± 1.2...

Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells

IL-24, also known as melanoma differentiation antigen 7 (mda-7), is a member of the IL-10 family of cytokines and is mainly produced by Th(2) cells as well as by activated monocytes. Binding of IL-24 to either of its two possible heterodimeric receptors IL-20R1/IL-20R2 and IL-22R/IL-20R2 activates STAT3 and/or STAT1 in target tissues such as lung, testis, ovary, keratinocytes and skin. To date,...

abstract

ABSTRACT